Clinical and pathogenetic substantiation of the use of Wobenzim in the complex treatment of generalized periodontitis.

Authors

  • I. S. Mashchenko
  • T. O. Kucherenko

DOI:

https://doi.org/10.26641/2307-0404.2018.2.133947

Keywords:

generalized periodontitis, wobenzym, monotherapy

Abstract

The purpose of this study was to determine the efficacy of using Wobenzim as a general therapy in the complex treatment of generalized periodontitis. 61 patients, I-II degree of severity, with tooth safety in an amount of at least 90%, without concomitant general pathology requiring treatment for the current time were examined. Comparative effectiveness of treatment was studied in 2 groups similar in all clinical indices. The main (31 people) patients, along with the symptomatic treatment received Wobenzim; control (30 people) - polytherapy (immunocorrecting, antioxidant, antimicrobial agents). As a result of the generally accepted clinical, paraclinical, immunological and biochemical studies conducted during the treatment and at long-term follow-up, it was found that the use of systemic enzyme therapy in this category of patients ensures rapid regression of the main clinical symptoms (on days 6-7), elimination of pathogenetic links of the disease more than in 90% of treated patients and the onset of remission for at least 6-12 months. It is characteristic that during the monotherapy with Wobenzim, positive results of treatment of generalized periodontitis were achieved, similar to those with the use of complex standard therapy, including administration of a number of medications with targeted action on pathogenesis mechanisms of the disease. From the position of evidence-based medicine, the expediency of replacing a broad arsenal of medicines in the complex treatment of generalized periodontitis with certain pharmacological preparations with a systemic effect is justified.

Author Biographies

I. S. Mashchenko

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
Oral Surgery, Implantology and Periodontology department
V. Vernadsky str., 9, Dnipro, 49044, Ukraine

T. O. Kucherenko

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
Oral Surgery, Implantology and Periodontology department
V. Vernadsky str., 9, Dnipro, 49044, Ukraine

References

Gudaryan AA, Shandyba SI. [Efficiency of local differentiated use of membranes in the surgical treatment of generalized periodontitis in patients with type 2 diabetes mellitus]. Visnyk stomatologii. 2014;3:79-83. Russian.

Gumeniuk MI. [Peculiarities of parodontologic sta­tus and local immunity of the oral cavity in patients with chronical obstructive diseases of lungs]. Novyny stomatologii. 2015;4:71-76. Ukrainian.

Demkovich AY. [Pathogenetic role of microbial persistence of a dental plaque in the mechanisms of de­velopment of generalized periodontitis: (literature re­view)]. Journal Clinic and experiment. honey. research. 2015;3(2):174-80. Ukrainian.

Dimitrova AG. [The prevalence and intensity of periodontal diseases in students of NMU]. Sovrem. sto­matologiya. 2015;3:23-25. Russian.

Dolzhikova EM, Sternin YuI Shuginina EA. [Pa­thogenetic substantiation and experience of application of systemic enzyme therapy in cosmetology and plastic surgery]. Regular issues of "RMZh". 2011;11:698. Russian.

Zorina OA, Kulakov AA, Grudyanov AI. [Micro­biocenosis of the oral cavity in norm and with inflam­matory periodontal diseases]. Stomatologiya. 2011;1:73-78. Russian.

Knorring GYu, Remezov AP. [The use of syste­mic enzyme therapy for the treatment of infectious diseases]. Terramedica. 2004;4:6-8. Russian.

Kulakova VI,NasonovaVA, Savel'eva VS. [Systemic enzyme therapy. Experience and prospects]. Sankt-Peterburg, Inter-Medika, 2004;264. Russian.

Mashchenko IS. [Inflammatory and dystrophic periodontal diseases: manual]. Dnipropetrovsk, ART-PRES. 2003;244. Ukrainian.

Mashchenko IS, Gudaryan AA. [Immuno­patho­genesis of various clinical forms of generalized perio­dontitis]. Visnyk stomatologii. 2012;2:41-46. Ukrainian.

Mashchenko IS, Gudaryan AA,DoroginaAS.[Causes of resistance of the main periodontal pathogens to antibacterial therapy in patients with fast-progressive generalized periodontitis]. Visnyk stomatologii. 2013;4:35-41. Russian.

http://irbis-nbuv.gov.ua/cgi-bin/irbis64r_81/cgiirbis_64.exe?Z21ID=&I21DBN=REF&P21DBN=REF&S21STN=1&S21REF=10&S21FMT=fullwebr&C21COM=S&S21CNR=20&S21P01=0&S21P02=0&S21P03=A=&S21COLORTERMS=1&S21STR=%D0%9C%D1%83%D1%85%D1%96%D0%BD%20%D0%86$">Mukhin IV. [Antioxidant effect of Wobenzim in patients with chronic glomerulonephritis]. Likarska sp­rava. 2007;1-2:58-61. Ukrainian.

Pashaev AC, Puri-Zahidan SV. [Antibacterial therapy of chronic generalized periodontitis]. Visnyk sto­matologii. 2014;4:93-97. Russian.

Sternin YuI, Mikhaylov IB. [Selected Issues in Clinical Pharmacology of Systemic Enzymotherapy: A Handbook for Physicians]. Sankt-Peterburg, InformMed. 2010;32. Russian.

Chuykin SV, Khasanov TA, Baimukhametov A. [The use of the drug Vobenzim in the complex treatment of acute purulent lymphadenitis of the maxillofacial region in children]. Medical Bulletin of Bashkortostan. 2011;6:82-84. Russian.

Ramseier CA. [Advanced reconstructive techno­logies for periodontal tissue repair]. Periodontal. 2000. 2012;59:185-202.

Aditi Mathur, Lalit Mathur, Balaji Manohar, Hemant Mathur, Rajesh Shankarapillai, Neema Shetty, and Aman Bhatia. [Antioxidant therapy as monotherapy or as an adjunct to treatment of periodontal diseases]. J Indian Soc Periodontol. 2013;17(1): 21-24.

Plessas A. [Nonsurgical periodontal treatment: review of the evidence]. Oral health dent. manag. 2014;13(1):71-80.

How to Cite

1.
Mashchenko IS, Kucherenko TO. Clinical and pathogenetic substantiation of the use of Wobenzim in the complex treatment of generalized periodontitis. Med. perspekt. [Internet]. 2018Jun.25 [cited 2024Mar.4];23(2):111-9. Available from: https://journals.uran.ua/index.php/2307-0404/article/view/133947

Issue

Section

CLINICAL MEDICINE